Counting the cost of complementary and alternative therapies in an Irish neurological clinic
- PMID: 19049557
- DOI: 10.1111/j.1468-1331.2008.02320.x
Counting the cost of complementary and alternative therapies in an Irish neurological clinic
Abstract
Background and purpose: Complementary and alternative therapy (CAT) use is frequent in patients with the common neurological disorders despite little scientific evidence of its efficacy. Little is known about the cost of regular CAT use. The purposes of this study were to determine the frequency and cost of CAT use in patients attending a neurology out-patient clinic and to determine whether neurological diagnosis affects CAT use.
Methods: All patients attending the neurology out-patient clinic were asked to complete a structured questionnaire which included demographic information, details on the underlying neurological diagnosis, use and cost of CAT.
Results: Six hundred and seventy-one patients completed the questionnaire. Over 60% of the patients had used CAT, and 25% used CAT on a regular basis. Only 25% of patients using CAT had informed their doctor. Rates of CAT use varied with neurological diagnosis. Of those using CAM on a regular basis, the mean annual cost was Euro 1351.
Conclusion: Patients attending our neurology out-patient department use CAT frequently and often do not inform their doctor. Patients spend a significant amount of personal income on CAT. Given the implications, including potential interactions with prescribed medication, these findings should prompt doctors to ask every patient about CAT use.
Similar articles
-
Use of complementary and alternative medical therapies in a pediatric neurology clinic.Can J Neurol Sci. 2005 Nov;32(4):524-8. doi: 10.1017/s0317167100004558. Can J Neurol Sci. 2005. PMID: 16408586
-
[Descriptive epidemiology of ambulatory neurological care in the Vega Baja (Alicante) area].Rev Neurol. 2002 Nov 1-15;35(9):822-6. Rev Neurol. 2002. PMID: 12436379 Spanish.
-
A descriptive analysis of ambulatory neurological care demand in Burgos Health Area.Neurologia. 2011 Jan-Feb;26(1):39-44. doi: 10.1016/j.nrl.2010.07.034. Epub 2010 Nov 26. Neurologia. 2011. PMID: 21163210 English, Spanish.
-
[Neurology].Rev Med Suisse. 2007 Jan 10;3(93):39-47. Rev Med Suisse. 2007. PMID: 17354660 Review. French.
-
[Use of alternative and complementary therapies in clinical practice using multiple sclerosis as an example].Dtsch Med Wochenschr. 2012 Mar;137(11):547-51. doi: 10.1055/s-0031-1298996. Epub 2012 Mar 6. Dtsch Med Wochenschr. 2012. PMID: 22396239 Review. German.
Cited by
-
Natural Products in Epilepsy-the Present Situation and Perspectives for the Future.Pharmaceuticals (Basel). 2010 May 12;3(5):1426-1445. doi: 10.3390/ph3051426. Pharmaceuticals (Basel). 2010. PMID: 27713311 Free PMC article. Review.
-
Use of bodily sensations as a risk assessment tool: exploring people with Multiple Sclerosis' views on risks of negative interactions between herbal medicine and conventional drug therapies.BMC Complement Altern Med. 2014 Feb 18;14:59. doi: 10.1186/1472-6882-14-59. BMC Complement Altern Med. 2014. PMID: 24533750 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous